Clinical Trial Update: A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD [Phase 1]

View source ↗

Summary

Phase 1 study of DD01 in overweight/obese adults with Type 2 diabetes and non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• DD01

Snippet

Sponsor: Neuraly, Inc. | Conditions: Overweight and Obesity, Type2 Diabetes | Phase 1 | Status: COMPLETED